As of 2023, it is estimated that colorectal cancer (CRC) will be the third most commonly diagnosed cancer in Canada, accounting for 11% of all new cancer diagnoses.1 Patients with localized CRCs have a 90% relative 5-year survival rate compared with 14% in those with distant metastases at diagnosis.2 While the incidence of CRC in individuals 65 years or older has declined steadily in the United States since the mid-1990s, the incidence in those 64 years or younger has increased.2 Based on...
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile